 SOUTH PLAINFIELD, N.J., June 23, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced that EvrysdiTM risdiplam was approved in Japan by the Japanese Ministry of Health, Labor and Welfare for the treatment of spinal muscular atrophy SMA. 